Global Pharmaceutics and Novel Drug Delivery Systems Market Size, Status and Forecast 2024-2031

Report ID: 920959 | Published Date: Feb 2026 | No. of Page: 126 | Base Year: 2025 | Rating: 4.1 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%)

Impact of U.S Tarrifs Analyzed 2025 

1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Pharmaceutics and Novel Drug Delivery Systems Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Liposomes
        1.2.3 PEGylated Proteins & Polypeptides
        1.2.4 Polymer Nanoparticle
        1.2.5 Protein–drug Conjugates
        1.2.6 Other
    1.3 Market by Application
        1.3.1 Global Pharmaceutics and Novel Drug Delivery Systems Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospitals & Clinic
        1.3.3 Cancer Treatment Centers
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Pharmaceutics and Novel Drug Delivery Systems Market Perspective (2016-2027)
    2.2 Pharmaceutics and Novel Drug Delivery Systems Growth Trends by Regions
        2.2.1 Pharmaceutics and Novel Drug Delivery Systems Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Pharmaceutics and Novel Drug Delivery Systems Historic Market Share by Regions (2016-2021)
        2.2.3 Pharmaceutics and Novel Drug Delivery Systems Forecasted Market Size by Regions (2022-2027)
    2.3 Pharmaceutics and Novel Drug Delivery Systems Industry Dynamic
        2.3.1 Pharmaceutics and Novel Drug Delivery Systems Market Trends
        2.3.2 Pharmaceutics and Novel Drug Delivery Systems Market Drivers
        2.3.3 Pharmaceutics and Novel Drug Delivery Systems Market Challenges
        2.3.4 Pharmaceutics and Novel Drug Delivery Systems Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Pharmaceutics and Novel Drug Delivery Systems Players by Revenue
        3.1.1 Global Top Pharmaceutics and Novel Drug Delivery Systems Players by Revenue (2016-2021)
        3.1.2 Global Pharmaceutics and Novel Drug Delivery Systems Revenue Market Share by Players (2016-2021)
    3.2 Global Pharmaceutics and Novel Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Pharmaceutics and Novel Drug Delivery Systems Revenue
    3.4 Global Pharmaceutics and Novel Drug Delivery Systems Market Concentration Ratio
        3.4.1 Global Pharmaceutics and Novel Drug Delivery Systems Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutics and Novel Drug Delivery Systems Revenue in 2020
    3.5 Pharmaceutics and Novel Drug Delivery Systems Key Players Head office and Area Served
    3.6 Key Players Pharmaceutics and Novel Drug Delivery Systems Product Solution and Service
    3.7 Date of Enter into Pharmaceutics and Novel Drug Delivery Systems Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Pharmaceutics and Novel Drug Delivery Systems Breakdown Data by Type
    4.1 Global Pharmaceutics and Novel Drug Delivery Systems Historic Market Size by Type (2016-2021)
    4.2 Global Pharmaceutics and Novel Drug Delivery Systems Forecasted Market Size by Type (2022-2027)

5 Pharmaceutics and Novel Drug Delivery Systems Breakdown Data by Application
    5.1 Global Pharmaceutics and Novel Drug Delivery Systems Historic Market Size by Application (2016-2021)
    5.2 Global Pharmaceutics and Novel Drug Delivery Systems Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Pharmaceutics and Novel Drug Delivery Systems Market Size (2016-2027)
    6.2 North America Pharmaceutics and Novel Drug Delivery Systems Market Size by Type
        6.2.1 North America Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2016-2021)
        6.2.2 North America Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2022-2027)
        6.2.3 North America Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2016-2027)
    6.3 North America Pharmaceutics and Novel Drug Delivery Systems Market Size by Application
        6.3.1 North America Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2016-2021)
        6.3.2 North America Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2022-2027)
        6.3.3 North America Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2016-2027)
    6.4 North America Pharmaceutics and Novel Drug Delivery Systems Market Size by Country
        6.4.1 North America Pharmaceutics and Novel Drug Delivery Systems Market Size by Country (2016-2021)
        6.4.2 North America Pharmaceutics and Novel Drug Delivery Systems Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Pharmaceutics and Novel Drug Delivery Systems Market Size (2016-2027)
    7.2 Europe Pharmaceutics and Novel Drug Delivery Systems Market Size by Type
        7.2.1 Europe Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2016-2021)
        7.2.2 Europe Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2022-2027)
        7.2.3 Europe Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2016-2027)
    7.3 Europe Pharmaceutics and Novel Drug Delivery Systems Market Size by Application
        7.3.1 Europe Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2016-2021)
        7.3.2 Europe Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2022-2027)
        7.3.3 Europe Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2016-2027)
    7.4 Europe Pharmaceutics and Novel Drug Delivery Systems Market Size by Country
        7.4.1 Europe Pharmaceutics and Novel Drug Delivery Systems Market Size by Country (2016-2021)
        7.4.2 Europe Pharmaceutics and Novel Drug Delivery Systems Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Pharmaceutics and Novel Drug Delivery Systems Market Size (2016-2027)
    8.2 Asia-Pacific Pharmaceutics and Novel Drug Delivery Systems Market Size by Type
        8.2.1 Asia-Pacific Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2016-2027)
    8.3 Asia-Pacific Pharmaceutics and Novel Drug Delivery Systems Market Size by Application
        8.3.1 Asia-Pacific Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2016-2027)
    8.4 Asia-Pacific Pharmaceutics and Novel Drug Delivery Systems Market Size by Region
        8.4.1 Asia-Pacific Pharmaceutics and Novel Drug Delivery Systems Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Pharmaceutics and Novel Drug Delivery Systems Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Pharmaceutics and Novel Drug Delivery Systems Market Size (2016-2027)
    9.2 Latin America Pharmaceutics and Novel Drug Delivery Systems Market Size by Type
        9.2.1 Latin America Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2016-2021)
        9.2.2 Latin America Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2022-2027)
        9.2.3 Latin America Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2016-2027)
    9.3 Latin America Pharmaceutics and Novel Drug Delivery Systems Market Size by Application
        9.3.1 Latin America Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2016-2021)
        9.3.2 Latin America Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2022-2027)
        9.3.3 Latin America Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2016-2027)
    9.4 Latin America Pharmaceutics and Novel Drug Delivery Systems Market Size by Country
        9.4.1 Latin America Pharmaceutics and Novel Drug Delivery Systems Market Size by Country (2016-2021)
        9.4.2 Latin America Pharmaceutics and Novel Drug Delivery Systems Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Pharmaceutics and Novel Drug Delivery Systems Market Size (2016-2027)
    10.2 Middle East & Africa Pharmaceutics and Novel Drug Delivery Systems Market Size by Type
        10.2.1 Middle East & Africa Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2016-2027)
    10.3 Middle East & Africa Pharmaceutics and Novel Drug Delivery Systems Market Size by Application
        10.3.1 Middle East & Africa Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2016-2027)
    10.4 Middle East & Africa Pharmaceutics and Novel Drug Delivery Systems Market Size by Country
        10.4.1 Middle East & Africa Pharmaceutics and Novel Drug Delivery Systems Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Pharmaceutics and Novel Drug Delivery Systems Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Amgen
        11.1.1 Amgen Company Details
        11.1.2 Amgen Business Overview
        11.1.3 Amgen Pharmaceutics and Novel Drug Delivery Systems Introduction
        11.1.4 Amgen Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
        11.1.5 Amgen Recent Development
    11.2 Teva
        11.2.1 Teva Company Details
        11.2.2 Teva Business Overview
        11.2.3 Teva Pharmaceutics and Novel Drug Delivery Systems Introduction
        11.2.4 Teva Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
        11.2.5 Teva Recent Development
    11.3 Roche
        11.3.1 Roche Company Details
        11.3.2 Roche Business Overview
        11.3.3 Roche Pharmaceutics and Novel Drug Delivery Systems Introduction
        11.3.4 Roche Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
        11.3.5 Roche Recent Development
    11.4 UCB (Union Chimique Belge)
        11.4.1 UCB (Union Chimique Belge) Company Details
        11.4.2 UCB (Union Chimique Belge) Business Overview
        11.4.3 UCB (Union Chimique Belge) Pharmaceutics and Novel Drug Delivery Systems Introduction
        11.4.4 UCB (Union Chimique Belge) Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
        11.4.5 UCB (Union Chimique Belge) Recent Development
    11.5 Celgene
        11.5.1 Celgene Company Details
        11.5.2 Celgene Business Overview
        11.5.3 Celgene Pharmaceutics and Novel Drug Delivery Systems Introduction
        11.5.4 Celgene Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
        11.5.5 Celgene Recent Development
    11.6 Merck
        11.6.1 Merck Company Details
        11.6.2 Merck Business Overview
        11.6.3 Merck Pharmaceutics and Novel Drug Delivery Systems Introduction
        11.6.4 Merck Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
        11.6.5 Merck Recent Development
    11.7 Gilead Sciences
        11.7.1 Gilead Sciences Company Details
        11.7.2 Gilead Sciences Business Overview
        11.7.3 Gilead Sciences Pharmaceutics and Novel Drug Delivery Systems Introduction
        11.7.4 Gilead Sciences Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
        11.7.5 Gilead Sciences Recent Development
    11.8 Sanofi
        11.8.1 Sanofi Company Details
        11.8.2 Sanofi Business Overview
        11.8.3 Sanofi Pharmaceutics and Novel Drug Delivery Systems Introduction
        11.8.4 Sanofi Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
        11.8.5 Sanofi Recent Development
    11.9 Pfizer
        11.9.1 Pfizer Company Details
        11.9.2 Pfizer Business Overview
        11.9.3 Pfizer Pharmaceutics and Novel Drug Delivery Systems Introduction
        11.9.4 Pfizer Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
        11.9.5 Pfizer Recent Development
    11.10 Takeda
        11.10.1 Takeda Company Details
        11.10.2 Takeda Business Overview
        11.10.3 Takeda Pharmaceutics and Novel Drug Delivery Systems Introduction
        11.10.4 Takeda Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
        11.10.5 Takeda Recent Development
    11.11 Bausch&Lomb
        11.11.1 Bausch&Lomb Company Details
        11.11.2 Bausch&Lomb Business Overview
        11.11.3 Bausch&Lomb Pharmaceutics and Novel Drug Delivery Systems Introduction
        11.11.4 Bausch&Lomb Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
        11.11.5 Bausch&Lomb Recent Development
    11.12 Samyang Biopharmaceuticals
        11.12.1 Samyang Biopharmaceuticals Company Details
        11.12.2 Samyang Biopharmaceuticals Business Overview
        11.12.3 Samyang Biopharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Introduction
        11.12.4 Samyang Biopharmaceuticals Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
        11.12.5 Samyang Biopharmaceuticals Recent Development
    11.13 Johnson & Johnson
        11.13.1 Johnson & Johnson Company Details
        11.13.2 Johnson & Johnson Business Overview
        11.13.3 Johnson & Johnson Pharmaceutics and Novel Drug Delivery Systems Introduction
        11.13.4 Johnson & Johnson Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
        11.13.5 Johnson & Johnson Recent Development
    11.14 TOLMAR
        11.14.1 TOLMAR Company Details
        11.14.2 TOLMAR Business Overview
        11.14.3 TOLMAR Pharmaceutics and Novel Drug Delivery Systems Introduction
        11.14.4 TOLMAR Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
        11.14.5 TOLMAR Recent Development
    11.15 Astellas
        11.15.1 Astellas Company Details
        11.15.2 Astellas Business Overview
        11.15.3 Astellas Pharmaceutics and Novel Drug Delivery Systems Introduction
        11.15.4 Astellas Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
        11.15.5 Astellas Recent Development
    11.16 AMAG Pharmaceuticals
        11.16.1 AMAG Pharmaceuticals Company Details
        11.16.2 AMAG Pharmaceuticals Business Overview
        11.16.3 AMAG Pharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Introduction
        11.16.4 AMAG Pharmaceuticals Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
        11.16.5 AMAG Pharmaceuticals Recent Development
    11.17 AbbVie
        11.17.1 AbbVie Company Details
        11.17.2 AbbVie Business Overview
        11.17.3 AbbVie Pharmaceutics and Novel Drug Delivery Systems Introduction
        11.17.4 AbbVie Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
        11.17.5 AbbVie Recent Development
    11.18 Dr Reddy
        11.18.1 Dr Reddy Company Details
        11.18.2 Dr Reddy Business Overview
        11.18.3 Dr Reddy Pharmaceutics and Novel Drug Delivery Systems Introduction
        11.18.4 Dr Reddy Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
        11.18.5 Dr Reddy Recent Development
    11.18 AstraZeneca
        .1 AstraZeneca Company Details
        .2 AstraZeneca Business Overview
        .3 AstraZeneca Pharmaceutics and Novel Drug Delivery Systems Introduction
        .4 AstraZeneca Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
        .5 AstraZeneca Recent Development
    11.20 Aspen
        11.20.1 Aspen Company Details
        11.20.2 Aspen Business Overview
        11.20.3 Aspen Pharmaceutics and Novel Drug Delivery Systems Introduction
        11.20.4 Aspen Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
        11.20.5 Aspen Recent Development
    11.21 Acrotech Biopharma
        11.21.1 Acrotech Biopharma Company Details
        11.21.2 Acrotech Biopharma Business Overview
        11.21.3 Acrotech Biopharma Pharmaceutics and Novel Drug Delivery Systems Introduction
        11.21.4 Acrotech Biopharma Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
        11.21.5 Acrotech Biopharma Recent Development
    11.22 TWi Pharmaceuticals
        11.22.1 TWi Pharmaceuticals Company Details
        11.22.2 TWi Pharmaceuticals Business Overview
        11.22.3 TWi Pharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Introduction
        11.22.4 TWi Pharmaceuticals Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
        11.22.5 TWi Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Pharmaceutics and Novel Drug Delivery Systems Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Liposomes
    Table 3. Key Players of PEGylated Proteins & Polypeptides
    Table 4. Key Players of Polymer Nanoparticle
    Table 5. Key Players of Protein–drug Conjugates
    Table 6. Key Players of Other
    Table 7. Global Pharmaceutics and Novel Drug Delivery Systems Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 8. Global Pharmaceutics and Novel Drug Delivery Systems Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 9. Global Pharmaceutics and Novel Drug Delivery Systems Market Size by Regions (2016-2021) & (US$ Million)
    Table 10. Global Pharmaceutics and Novel Drug Delivery Systems Market Share by Regions (2016-2021)
    Table 11. Global Pharmaceutics and Novel Drug Delivery Systems Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 12. Global Pharmaceutics and Novel Drug Delivery Systems Market Share by Regions (2022-2027)
    Table 13. Pharmaceutics and Novel Drug Delivery Systems Market Trends
    Table 14. Pharmaceutics and Novel Drug Delivery Systems Market Drivers
    Table 15. Pharmaceutics and Novel Drug Delivery Systems Market Challenges
    Table 16. Pharmaceutics and Novel Drug Delivery Systems Market Restraints
    Table 17. Global Pharmaceutics and Novel Drug Delivery Systems Revenue by Players (2016-2021) & (US$ Million)
    Table 18. Global Pharmaceutics and Novel Drug Delivery Systems Market Share by Players (2016-2021)
    Table 19. Global Top Pharmaceutics and Novel Drug Delivery Systems Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmaceutics and Novel Drug Delivery Systems as of 2020)
    Table 20. Ranking of Global Top Pharmaceutics and Novel Drug Delivery Systems Companies by Revenue (US$ Million) in 2020
    Table 21. Global 5 Largest Players Market Share by Pharmaceutics and Novel Drug Delivery Systems Revenue (CR5 and HHI) & (2016-2021)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Pharmaceutics and Novel Drug Delivery Systems Product Solution and Service
    Table 24. Date of Enter into Pharmaceutics and Novel Drug Delivery Systems Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2016-2021) (US$ Million)
    Table 27. Global Pharmaceutics and Novel Drug Delivery Systems Revenue Market Share by Type (2016-2021)
    Table 28. Global Pharmaceutics and Novel Drug Delivery Systems Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 29. Global Pharmaceutics and Novel Drug Delivery Systems Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 30. Global Pharmaceutics and Novel Drug Delivery Systems Market Size Share by Application (2016-2021) & (US$ Million)
    Table 31. Global Pharmaceutics and Novel Drug Delivery Systems Revenue Market Share by Application (2016-2021)
    Table 32. Global Pharmaceutics and Novel Drug Delivery Systems Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 33. Global Pharmaceutics and Novel Drug Delivery Systems Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 34. North America Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2016-2021) (US$ Million)
    Table 35. North America Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2022-2027) & (US$ Million)
    Table 36. North America Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2016-2021) (US$ Million)
    Table 37. North America Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2022-2027) & (US$ Million)
    Table 38. North America Pharmaceutics and Novel Drug Delivery Systems Market Size by Country (2016-2021) & (US$ Million) 
    Table 39. North America Pharmaceutics and Novel Drug Delivery Systems Market Size by Country (2022-2027) & (US$ Million) 
    Table 40. Europe Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2016-2021) (US$ Million)
    Table 41. Europe Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2022-2027) & (US$ Million)
    Table 42. Europe Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2016-2021) (US$ Million)
    Table 43. Europe Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2022-2027) & (US$ Million)
    Table 44. Europe Pharmaceutics and Novel Drug Delivery Systems Market Size by Country (2016-2021) & (US$ Million) 
    Table 45. Europe Pharmaceutics and Novel Drug Delivery Systems Market Size by Country (2022-2027) & (US$ Million) 
    Table 46. Asia-Pacific Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2016-2021) (US$ Million)
    Table 47. Asia-Pacific Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2016-2021) (US$ Million)
    Table 49. Asia-Pacific Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2022-2027) & (US$ Million)
    Table 50. Asia-Pacific Pharmaceutics and Novel Drug Delivery Systems Market Size by Region (2016-2021) & (US$ Million) 
    Table 51. Asia-Pacific Pharmaceutics and Novel Drug Delivery Systems Market Size by Region (2022-2027) & (US$ Million) 
    Table 52. Latin America Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2016-2021) (US$ Million)
    Table 53. Latin America Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2022-2027) & (US$ Million)
    Table 54. Latin America Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2016-2021) (US$ Million)
    Table 55. Latin America Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2022-2027) & (US$ Million)
    Table 56. Latin America Pharmaceutics and Novel Drug Delivery Systems Market Size by Country (2016-2021) & (US$ Million) 
    Table 57. Latin America Pharmaceutics and Novel Drug Delivery Systems Market Size by Country (2022-2027) & (US$ Million) 
    Table 58. Middle East & Africa Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2016-2021) (US$ Million)
    Table 59. Middle East & Africa Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2016-2021) (US$ Million)
    Table 61. Middle East & Africa Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2022-2027) & (US$ Million)
    Table 62. Middle East & Africa Pharmaceutics and Novel Drug Delivery Systems Market Size by Country (2016-2021) & (US$ Million) 
    Table 63. Middle East & Africa Pharmaceutics and Novel Drug Delivery Systems Market Size by Country (2022-2027) & (US$ Million) 
    Table 64. Amgen Company Details
    Table 65. Amgen Business Overview
    Table 66. Amgen Pharmaceutics and Novel Drug Delivery Systems Product
    Table 67. Amgen Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021) & (US$ Million)
    Table 68. Amgen Recent Development
    Table 69. Teva Company Details
    Table 70. Teva Business Overview
    Table 71. Teva Pharmaceutics and Novel Drug Delivery Systems Product
    Table 72. Teva Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021) & (US$ Million)
    Table 73. Teva Recent Development
    Table 74. Roche Company Details
    Table 75. Roche Business Overview
    Table 76. Roche Pharmaceutics and Novel Drug Delivery Systems Product
    Table 77. Roche Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021) & (US$ Million)
    Table 78. Roche Recent Development
    Table 79. UCB (Union Chimique Belge) Company Details
    Table 80. UCB (Union Chimique Belge) Business Overview
    Table 81. UCB (Union Chimique Belge) Pharmaceutics and Novel Drug Delivery Systems Product
    Table 82. UCB (Union Chimique Belge) Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021) & (US$ Million)
    Table 83. UCB (Union Chimique Belge) Recent Development
    Table 84. Celgene Company Details
    Table 85. Celgene Business Overview
    Table 86. Celgene Pharmaceutics and Novel Drug Delivery Systems Product
    Table 87. Celgene Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021) & (US$ Million)
    Table 88. Celgene Recent Development
    Table 89. Merck Company Details
    Table 90. Merck Business Overview
    Table 91. Merck Pharmaceutics and Novel Drug Delivery Systems Product
    Table 92. Merck Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021) & (US$ Million)
    Table 93. Merck Recent Development
    Table 94. Gilead Sciences Company Details
    Table 95. Gilead Sciences Business Overview
    Table 96. Gilead Sciences Pharmaceutics and Novel Drug Delivery Systems Product
    Table 97. Gilead Sciences Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021) & (US$ Million)
    Table 98. Gilead Sciences Recent Development
    Table 99. Sanofi Company Details
    Table 100. Sanofi Business Overview
    Table 101. Sanofi Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021) & (US$ Million)
    Table 102. Sanofi Recent Development
    Table 103. Pfizer Company Details
    Table 104. Pfizer Business Overview
    Table 105. Pfizer Pharmaceutics and Novel Drug Delivery Systems Product
    Table 106. Pfizer Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021) & (US$ Million)
    Table 107. Pfizer Recent Development
    Table 108. Takeda Company Details
    Table 109. Takeda Business Overview
    Table 110. Takeda Pharmaceutics and Novel Drug Delivery Systems Product
    Table 111. Takeda Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021) & (US$ Million)
    Table 112. Takeda Recent Development
    Table 113. Bausch&Lomb Company Details
    Table 114. Bausch&Lomb Business Overview
    Table 115. Bausch&Lomb Pharmaceutics and Novel Drug Delivery Systems Product
    Table 116. Bausch&Lomb Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021) & (US$ Million)
    Table 117. Bausch&Lomb Recent Development
    Table 118. Samyang Biopharmaceuticals Company Details
    Table 119. Samyang Biopharmaceuticals Business Overview
    Table 120. Samyang Biopharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Product
    Table 121. Samyang Biopharmaceuticals Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021) & (US$ Million)
    Table 122. Samyang Biopharmaceuticals Recent Development
    Table 123. Johnson & Johnson Company Details
    Table 124. Johnson & Johnson Business Overview
    Table 125. Johnson & Johnson Pharmaceutics and Novel Drug Delivery Systems Product
    Table 126. Johnson & Johnson Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021) & (US$ Million)
    Table 127. Johnson & Johnson Recent Development
    Table 128. TOLMAR Company Details
    Table 129. TOLMAR Business Overview
    Table 130. TOLMAR Pharmaceutics and Novel Drug Delivery Systems Product
    Table 131. TOLMAR Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021) & (US$ Million)
    Table 132. TOLMAR Recent Development
    Table 133. Astellas Company Details
    Table 134. Astellas Business Overview
    Table 135. Astellas Pharmaceutics and Novel Drug Delivery Systems Product
    Table 136. Astellas Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021) & (US$ Million)
    Table 137. Astellas Recent Development
    Table 138. AMAG Pharmaceuticals Company Details
    Table 139. AMAG Pharmaceuticals Business Overview
    Table 140. AMAG Pharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Product
    Table 141. AMAG Pharmaceuticals Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021) & (US$ Million)
    Table 142. AMAG Pharmaceuticals Recent Development
    Table 143. AbbVie Company Details
    Table 144. AbbVie Business Overview
    Table 145. AbbVie Pharmaceutics and Novel Drug Delivery Systems Product
    Table 146. AbbVie Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021) & (US$ Million)
    Table 147. AbbVie Recent Development
    Table 148. Dr Reddy Company Details
    Table 149. Dr Reddy Business Overview
    Table 150. Dr Reddy Pharmaceutics and Novel Drug Delivery Systems Product
    Table 151. Dr Reddy Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021) & (US$ Million)
    Table 152. Dr Reddy Recent Development
    Table 153. AstraZeneca Company Details
    Table 154. AstraZeneca Business Overview
    Table 155. AstraZeneca Pharmaceutics and Novel Drug Delivery Systems Product
    Table 156. AstraZeneca Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021) & (US$ Million)
    Table 157. AstraZeneca Recent Development
    Table 158. Aspen Company Details
    Table 159. Aspen Business Overview
    Table 160. Aspen Pharmaceutics and Novel Drug Delivery Systems Product
    Table 161. Aspen Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021) & (US$ Million)
    Table 162. Aspen Recent Development
    Table 163. Acrotech Biopharma Company Details
    Table 164. Acrotech Biopharma Business Overview
    Table 165. Acrotech Biopharma Pharmaceutics and Novel Drug Delivery Systems Product
    Table 166. Acrotech Biopharma Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021) & (US$ Million)
    Table 167. Acrotech Biopharma Recent Development
    Table 168. TWi Pharmaceuticals Company Details
    Table 169. TWi Pharmaceuticals Business Overview
    Table 170. TWi Pharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Product
    Table 171. TWi Pharmaceuticals Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021) & (US$ Million)
    Table 172. TWi Pharmaceuticals Recent Development
    Table 173. Research Programs/Design for This Report
    Table 174. Key Data Information from Secondary Sources
    Table 175. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Pharmaceutics and Novel Drug Delivery Systems Market Share by Type: 2020 VS 2027
    Figure 2. Liposomes Features
    Figure 3. PEGylated Proteins & Polypeptides Features
    Figure 4. Polymer Nanoparticle Features
    Figure 5. Protein–drug Conjugates Features
    Figure 6. Other Features
    Figure 7. Global Pharmaceutics and Novel Drug Delivery Systems Market Share by Application: 2020 VS 2027
    Figure 8. Hospitals & Clinic Case Studies
    Figure 9. Cancer Treatment Centers Case Studies
    Figure 10. Others Case Studies
    Figure 11. Pharmaceutics and Novel Drug Delivery Systems Report Years Considered
    Figure 12. Global Pharmaceutics and Novel Drug Delivery Systems Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 13. Global Pharmaceutics and Novel Drug Delivery Systems Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 14. Global Pharmaceutics and Novel Drug Delivery Systems Market Share by Regions: 2020 VS 2027
    Figure 15. Global Pharmaceutics and Novel Drug Delivery Systems Market Share by Regions (2022-2027)
    Figure 16. Global Pharmaceutics and Novel Drug Delivery Systems Market Share by Players in 2020
    Figure 17. Global Top Pharmaceutics and Novel Drug Delivery Systems Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmaceutics and Novel Drug Delivery Systems as of 2020
    Figure 18. The Top 10 and 5 Players Market Share by Pharmaceutics and Novel Drug Delivery Systems Revenue in 2020
    Figure 19. Global Pharmaceutics and Novel Drug Delivery Systems Revenue Market Share by Type (2016-2021)
    Figure 20. Global Pharmaceutics and Novel Drug Delivery Systems Revenue Market Share by Type (2022-2027)
    Figure 21. North America Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 22. North America Pharmaceutics and Novel Drug Delivery Systems Market Share by Type (2016-2027)
    Figure 23. North America Pharmaceutics and Novel Drug Delivery Systems Market Share by Application (2016-2027)
    Figure 24. North America Pharmaceutics and Novel Drug Delivery Systems Market Share by Country (2016-2027)
    Figure 25. United States Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Canada Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Europe Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 28. Europe Pharmaceutics and Novel Drug Delivery Systems Market Share by Type (2016-2027)
    Figure 29. Europe Pharmaceutics and Novel Drug Delivery Systems Market Share by Application (2016-2027)
    Figure 30. Europe Pharmaceutics and Novel Drug Delivery Systems Market Share by Country (2016-2027)
    Figure 31. Germany Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. France Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. U.K. Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Italy Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Russia Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Nordic Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Asia-Pacific Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Asia-Pacific Pharmaceutics and Novel Drug Delivery Systems Market Share by Type (2016-2027)
    Figure 39. Asia-Pacific Pharmaceutics and Novel Drug Delivery Systems Market Share by Application (2016-2027)
    Figure 40. Asia-Pacific Pharmaceutics and Novel Drug Delivery Systems Market Share by Region (2016-2027)
    Figure 41. China Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Japan Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. South Korea Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Southeast Asia Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. India Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Australia Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Latin America Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Latin America Pharmaceutics and Novel Drug Delivery Systems Market Share by Type (2016-2027)
    Figure 49. Latin America Pharmaceutics and Novel Drug Delivery Systems Market Share by Application (2016-2027)
    Figure 50. Latin America Pharmaceutics and Novel Drug Delivery Systems Market Share by Country (2016-2027)
    Figure 51. Mexico Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Brazil Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Middle East & Africa Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 54. Middle East & Africa Pharmaceutics and Novel Drug Delivery Systems Market Share by Type (2016-2027)
    Figure 55. Middle East & Africa Pharmaceutics and Novel Drug Delivery Systems Market Share by Application (2016-2027)
    Figure 56. Middle East & Africa Pharmaceutics and Novel Drug Delivery Systems Market Share by Country (2016-2027)
    Figure 57. Turkey Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. Saudi Arabia Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. UAE Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 60. Amgen Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
    Figure 61. Teva Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
    Figure 62. Roche Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
    Figure 63. UCB (Union Chimique Belge) Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
    Figure 64. Celgene Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
    Figure 65. Merck Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
    Figure 66. Gilead Sciences Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
    Figure 67. Sanofi Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
    Figure 68. Pfizer Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
    Figure 69. Takeda Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
    Figure 70. Bausch&Lomb Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
    Figure 71. Samyang Biopharmaceuticals Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
    Figure 72. Johnson & Johnson Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
    Figure 73. TOLMAR Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
    Figure 74. Astellas Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
    Figure 75. AMAG Pharmaceuticals Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
    Figure 76. AbbVie Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
    Figure 77. Dr Reddy Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
    Figure 78. AstraZeneca Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
    Figure 79. Aspen Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
    Figure 80. Acrotech Biopharma Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
    Figure 81. TWi Pharmaceuticals Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2016-2021)
    Figure 82. Bottom-up and Top-down Approaches for This Report
    Figure 83. Data Triangulation
    Figure 84. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Amgen
Teva
Roche
UCB (Union Chimique Belge)
Celgene
Merck
Gilead Sciences
Sanofi
Pfizer
Takeda
Bausch&Lomb
Samyang Biopharmaceuticals
Johnson & Johnson
TOLMAR
Astellas
AMAG Pharmaceuticals
AbbVie
Dr Reddy
AstraZeneca
Aspen
Acrotech Biopharma
TWi Pharmaceuticals
Frequently Asked Questions
Pharmaceutics and Novel Drug Delivery Systems report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Pharmaceutics and Novel Drug Delivery Systems report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Pharmaceutics and Novel Drug Delivery Systems report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Pet Diabetes Care

Most pet diabetes occurs in middle aged and middle aged cats, with females at twice the rate of m ... Read More